School of Medicine
Showing 11-19 of 19 Results
Director, Stanford Cancer Institute, Jerome and Daisy Low Gilbert Professor and Professor of Biochemistry
Current Research and Scholarly Interests Telomeres are nucleoprotein complexes that protect chromosome ends and shorten with cell division and aging. We are interested in how telomere shortening influences cancer, stem cell function, aging and human disease. Telomerase is a reverse transcriptase that synthesizes telomere repeats and is expressed in stem cells and in cancer. We have found that telomerase also regulates stem cells and we are pursuing the function of telomerase through diverse genetic and biochemical approaches.
Ann M. Arvin
Lucile Salter Packard Professor of Pediatrics and Professor of Microbiology and Immunology
Current Research and Scholarly Interests Our laboratory investigates the pathogenesis of varicella zoster virus (VZV) infection, focusing on the functional roles of particular viral gene products in pathogenesis and virus-cell interactions in differentiated human cells in humans and in Scid-hu mouse models of VZV cell tropisms in vivo, and the immunobiology of VZV infections.
Associate Professor of Medicine (Primary Care and Population Health) and of Anesthesiology, Perioperative and Pain Medicine at the Stanford University Medical Center
Bio Dr. Rebecca A. Aslakson is an Associate Professor at Stanford University with appointments in both the Department of Primary Care & Population Health in the Palliative Care Section and the Department of Anesthesiology, Perioperative and Pain Medicine where she serves as Division Chief of Critical Care Anesthesia. With a Summa Cum Laude B.A. from Washington University in St. Louis, an MD from Harvard Medical School?MIT, and an MSci degree with Distinction from the University of Ulster in Northern Ireland, Dr. Aslakson completed anesthesia residency at Massachusetts General Hospital and surgical critical care fellowship at The Johns Hopkins Hospital, where she was on faculty from 2008-2017. In 2013, Dr. Aslakson obtained her PhD in Clinical Investigations from The Johns Hopkins Bloomberg School of Public Health with her dissertation concerning integration of palliative care in intensive care units. Triple boarded in anesthesia, surgical critical care, and palliative medicine, Dr. Aslakson is an active researcher and clinician; her goal is to improve delivery of effective and equitable palliative care, particularly to perioperative and critically ill populations. She has published over 80 peer-reviewed papers, invited editorials, and book chapters and received competitive funding from funders such as AHRQ, PCORI, the Foundation for Anesthesia Education and Research, and the National Palliative Care Research Society. Dr. Aslakson serves on national committees for professional societies including the American Academy of Hospice and Palliative Medicine (AAHPM), the American Society of Anesthesiologists (ASA), and the Society of Critical Care Medicine (SCCM). Dr. Aslakson has received national awards including the 2015 AAHPM Early Career Investigator Award and the 2014 ASA Presidential Scholar Award. Dr. Aslakson clinically attends at the Stanford University Medical Center in the M4 and E2 Intensive Care Units and on the inpatient palliative care clinical service. She lives in Palo Alto, CA with her husband and two sons.
Ph.D. Student in Cancer Biology, admitted Autumn 2014
Current Research and Scholarly Interests As part of my graduate work I developed ImmunoGlobe, a map of the immune intercellular interactome that describes how immune cells and immune system components interact to drive immune responses. By structuring our knowledge of immune interactions into a directional graph, ImmunoGlobe makes it easy to explore the relationships between components of the immune system. An interactive version of the network is available online at immunoglobe.org.
Professor of Radiation Oncology (Radiation and Cancer Biology) and of Genetics
Current Research and Scholarly Interests Our research is aimed at defining the pathways of p53-mediated apoptosis and tumor suppression, using a combination of biochemical, cell biological, and mouse genetic approaches. Our strategy is to start by generating hypotheses about p53 mechanisms of action using primary mouse embryo fibroblasts (MEFs), and then to test them using gene targeting technology in the mouse.
Professor of Pathology
Current Research and Scholarly Interests Genetic and cell biological analyses of signals controlling cell polarity and morphogenesis. Frizzled signaling and cytoskeletal organization.